BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2752132)

  • 21. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Diviné M; Lepage E; Brière J; Pautier P; Dupriez B; Lederlin P; Mineur P; Tilly H; Blanc M; Audhuy B; Herbrecht R; Coiffier B; Reyes F
    J Clin Oncol; 1996 Jan; 14(1):240-8. PubMed ID: 8558204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
    Fuller LM; Krasin MJ; Velasquez WS; Allen PK; McLaughlin P; Rodriguez MA; Hagemeister FB; Swan F; Cabanillas F; Palmer JL
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):3-11. PubMed ID: 7527799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
    Rodriguez J; McLaughlin P; Hagemeister FB; Fayad L; Rodriguez MA; Santiago M; Hess M; Romaguera J; Cabanillas F
    Blood; 1999 Apr; 93(7):2202-7. PubMed ID: 10090928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
    Linassier C; Desablens B; Lefrancq T; Le Prise PY; Harousseau JL; Jacob C; Gandhour C; Haillot O; Lucas V; Leloup R; Escoffre M; Colombat P; Tabuteau S;
    Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
    Danieu L; Wong G; Koziner B; Clarkson B
    Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis.
    Meusers P; Engelhard M; Bartels H; Binder T; Fülle HH; Görg K; Gunzer U; Havemann K; Kayser W; König E
    Hematol Oncol; 1989; 7(5):365-80. PubMed ID: 2670728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
    Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
    Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
    Touroutoglou N; Dimopoulos MA; Younes A; Hess M; Pugh W; Cox J; Cabanillas F; Sarris AH
    J Clin Oncol; 1995 Jun; 13(6):1361-7. PubMed ID: 7751880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CHOP-Bleo therapy in high-malignancy non-Hodgkin lymphoma].
    Schneider T; Molnár Z; Várady E; Ringwald G; Fleischmann T
    Orv Hetil; 1994 Dec; 135(50):2759-63. PubMed ID: 7530823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
    Stewart DA; Bahlis N; Valentine K; Balogh A; Savoie L; Morris DG; Jones A; Brown C; Russell JA
    Blood; 2006 Jun; 107(12):4623-7. PubMed ID: 16467197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
    Hagemeister FB
    Leuk Lymphoma; 1993; 10 Suppl():21-7. PubMed ID: 7683228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
    J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.